No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
390 |
4. Check minimum number of eventsNone |
390 |
5. Include endpointsNone |
390 |
6. Filter based on genotype QC (FinnGen only) |
348 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D30
- Name in latin
- Neoplasma benignum vesicae urinariae
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Bladder
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm of urinary organs
- Benign neoplasms
- Neoplasms
- Any operation in hilmo
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2475 | 947 | 1483 |
| Only index persons | 1772 | 757 | 1015 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.03 | 0.04 |
| Only index persons | 0.03 | 0.03 | 0.04 |
| Median age at first event (years) | |||
| Whole population | 63.13 | 60.11 | 64.96 |
| Only index persons | 61.04 | 57.95 | 63.34 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 348 | 124 | 224 |
| Unadjusted period prevalence (%) | 0.08 | 0.04 | 0.10 |
| Median age at first event (years) | 63.08 | 56.21 | 66.88 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 355
- Matched controls
- 3546
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D30.3
ICD-10 Finland
Benign neoplasm: Bladder
+∞
307.7
296
*
KCD02
NOMESCO Finland
Transurethral resection of bladder
39.9
209.0
140
57
UKC02
NOMESCO Finland
Cystoscopy
20.2
174.0
273
502
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
37.3
160.4
106
40
KCD32
NOMESCO Finland
Cystoscopic destruction of tumour of bladder
60.7
91.9
52
10
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
20.6
89.9
73
44
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
17.2
65.3
57
39
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
20.9
62.2
49
27
R31
ICD-10 Finland
Unspecified haematuria
6.4
61.5
139
322
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
17.7
60.9
52
34
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
21.0
58.7
46
25
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
24.3
58.6
43
20
2233A
ICD-9 Finland
Benign neoplasm of kidney and other urinary organs, Bladder
+∞
39.3
37
*
22330
ICD-8 Finland
Benign neoplasm of kidney and other urinary organs, Bladder
+∞
29.6
28
*
1530
FHL
Urethrocystoscopy
9.1
28.7
37
45
7323
FHL
Electrosection of TU bladder wall change
101.0
26.0
28
*
D30.0
ICD-10 Finland
Benign neoplasm: Kidney
41.5
22.0
27
7
8120/1-C67.9
ICD-O-3
Urothelial papilloma, NOS, of bladder, NOS
188.8
17.7
18
*
7321
FHL
TU biopsy, coagulation or laser
40.0
15.5
19
5
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.8
15.4
51
149
WX320
NOMESCO Finland
Spinalanesthesy
2.6
14.9
123
608
KCB00
NOMESCO Finland
Biopsy of bladder
44.4
14.2
17
*
8130/1-C67.9
ICD-O-3
Papillary urothelial neoplasm of low malignant potential of bladder, NOS
41.7
13.3
16
*
J01EA01
ATC
trimethoprim; systemic
2.3
11.5
114
600
JN3AD
NOMESCO Finland
Abdominal CT examination
2.7
11.1
67
279
C67.1
ICD-10 Finland
Malignant neoplasm: Dome of bladder
61.8
10.7
12
*
J01MA02
ATC
ciprofloxacin; systemic
2.1
10.0
172
1113
KCW96
NOMESCO Finland
Other operations on bladder
20.7
9.9
14
7
C67.4
ICD-10 Finland
Malignant neoplasm: Posterior wall of bladder
56.5
9.7
11
*
1888X
ICD-9 Finland
Malignant neoplasm of bladder, Other specified sites of bladder
37.7
9.1
11
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.1
8.5
104
587
TKC20
NOMESCO Finland
Catheterisation of bladder
2.8
8.3
45
177
ZXE00
NOMESCO Finland
One hour or less
1.9
7.9
146
948
KCW02
NOMESCO Finland
Lavation of bladder for coagulated blood
7.2
7.9
18
26
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
4.0
7.8
22
57
18899
ICD-8 Finland
Malignant neoplasm of bladder
46.0
7.7
9
*
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.1
7.5
80
426
R33
ICD-10 Finland
Retention of urine
2.4
7.5
58
271
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.2
7.5
72
369
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.2
7.2
66
331
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
9.0
7.1
14
16
C67.0
ICD-10 Finland
Malignant neoplasm: Trigone of bladder
10.3
7.1
13
13
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
7.0
118
737
C67
ICD-10 Finland
Malignant neoplasm of bladder
17.1
6.8
10
6
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
7.4
6.8
15
21
N39.3
ICD-10 Finland
Stress incontinence
3.1
6.7
28
95
XKD00
NOMESCO Finland
Uroflowmetry
1.9
6.3
89
524
UJF32
NOMESCO Finland
Coloscopy
1.9
6.3
107
669
J01DB01
ATC
cefalexin; oral
2.0
6.1
282
2353
ZX136
NOMESCO Finland
Intravesicalis
8.8
6.1
12
14
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
168
1068
2.08
10.34
7.5
3.7
95.05
112.81
e6/l
0.09
138
831
129
765
2.08
9.37
4.9
2.9
3.49
4.28
e6/l
0.55
121
700
63
277
2.55
9.33
3.7
2.7
0.33
0.62
e6/l
0.43
63
266
144
916
1.96
8.40
7.5
3.6
0.24
0.51
e6/l
1.50
115
689
213
1551
1.93
8.21
6.0
4.3
54.90
4.80
estimate
0.69
49
339
214
1569
1.91
7.99
6.1
4.3
0.00
0.98
estimate
0.51
44
310
209
1531
1.88
7.71
6.1
4.3
0.00
0.00
estimate
-0.00
47
329
254
1987
1.97
7.62
9.6
5.0
3328.17
462.74
e6/l
—
6
35
95
558
1.96
6.77
7.3
3.1
1.51
1.02
e6/l
0.44
63
301
90
533
1.92
6.21
7.5
3.3
2.96
1.84
e6/l
0.37
57
279
132
904
1.73
5.57
2.6
2.2
2.75
3.03
mg/l
0.80
114
776
55
288
2.07
5.33
2.1
3.1
65.27
66.12
g/l
0.34
50
263
182
1383
1.65
5.04
3.4
2.8
—
—
estimate
—
0
0
205
1611
1.64
4.92
8.9
7.4
1.20
1.21
mmol/l
1.01
175
1383
175
1324
1.63
4.88
3.8
3.0
134.36
146.91
ug/l
0.31
165
1224
10
14
7.31
4.68
1.8
1.9
12.50
15.86
%
—
10
14
119
824
1.67
4.67
5.0
3.9
0.00
0.11
estimate
0.58
35
255
154
1157
1.58
4.25
5.9
4.3
0.00
0.04
estimate
1.32
41
275
9
14
6.56
4.00
2.1
1.9
—
—
—
0
0
195
1566
1.54
3.89
21.2
16.5
1.35
1.33
inr
0.22
179
1313
182
1458
1.51
3.56
7.6
6.7
1.20
1.21
mmol/l
0.67
167
1332
199
1635
1.49
3.37
8.8
7.0
11.12
12.30
umol/l
1.57
194
1559
118
888
1.49
3.02
5.8
4.3
0.00
0.01
estimate
0.50
42
297
200
1673
1.44
2.92
12.2
9.6
4.22
4.36
e9/l
0.37
177
1432
139
1090
1.45
2.85
3.7
3.4
7.15
7.59
mmol/l
0.65
118
899
23
111
2.14
2.79
2.2
4.7
1.40
3.72
ratio
1.69
16
65
18
78
2.37
2.79
1.3
1.5
0.22
0.04
iu/ml
—
6
19
54
347
1.65
2.74
4.2
3.8
—
—
—
0
0
214
1826
1.43
2.72
6.6
5.2
6.93
6.79
mmol/l
0.46
208
1739
138
1095
1.42
2.61
5.2
4.1
7.55
10.49
mg/mmol
0.79
90
703
173
1429
1.41
2.60
6.7
5.2
34.10
34.90
g/l
1.05
165
1348
10
31
3.28
2.53
1.9
2.3
—
—
—
0
0
95
708
1.46
2.50
1.8
1.8
385.82
9794253.56
pmol/l
0.50
77
582
92
684
1.46
2.44
5.7
4.4
1.02
1.02
kg/l
0.08
71
445
61
416
1.56
2.43
6.8
7.3
0.39
0.91
mmol/l
0.62
49
349
15
66
2.33
2.27
1.4
1.2
—
0.88
—
0
5
141
1147
1.38
2.23
4.1
3.4
1833.40
1671.95
ng/l
0.21
123
996
172
1447
1.36
2.20
2.9
2.3
95.45
94.77
pmol/l
0.07
89
784
38
237
1.67
2.18
1.8
1.6
—
—
—
0
0
86
646
1.44
2.15
1.7
1.8
1043.42
1163.77
nmol/l
0.67
65
495
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
20
102
2.02
2.14
3.5
2.4
0.34
0.40
iu/ml
—
8
56
106
831
1.39
2.08
3.5
3.1
377.04
357.59
umol/l
0.92
89
711
34
209
1.69
2.06
5.6
3.3
1.39
1.84
mmol/l
0.24
25
155
121
972
1.37
2.04
3.4
2.6
54.87
64.49
u/l
0.75
116
899
29
172
1.75
1.99
1.3
1.4
—
—
—
0
0
302
2807
1.50
1.99
32.6
23.1
4.01
4.01
mmol/l
0.01
297
2742
231
2052
1.36
1.99
4.8
4.1
14.93
14.99
pmol/l
0.11
202
1832
294
2720
1.46
1.97
28.4
18.8
22.90
26.65
mg/l
1.42
262
2314
35
220
1.65
1.96
2.4
1.7
—
—
—
0
0
97
758
1.38
1.92
3.1
2.4
—
—
—
0
0
153
1288
1.33
1.86
2.8
2.5
75.49
76.93
nmol/l
0.23
140
1123
62
450
1.46
1.85
2.2
1.8
—
—
—
0
0
5
12
4.20
1.82
2.2
7.6
—
—
—
0
0
44
299
1.54
1.80
7.3
7.8
1.32
1.29
mmol/l
0.05
44
292
197
1730
1.31
1.73
4.7
3.4
56.46
54.81
u/l
0.09
188
1602
8
31
2.61
1.66
3.4
1.2
—
—
—
0
0
22
128
1.76
1.64
2.3
1.7
—
—
—
0
0
130
1086
1.31
1.63
4.1
3.4
2.36
2.35
mmol/l
0.38
117
968
42
290
1.51
1.61
2.7
2.1
378.22
394.33
nmol/l
0.21
37
269
15
77
1.99
1.61
1.4
1.6
—
—
—
0
0
272
2511
1.35
1.61
6.3
5.2
2.16
1.98
mu/l
0.80
250
2255
10
43
2.36
1.60
1.2
1.5
13920.00
191.25
u/l
—
5
12
7
26
2.72
1.58
1.0
1.1
—
—
—
0
0
64
482
1.40
1.57
8.9
6.9
104.86
104.35
mmol/l
0.50
64
482
25
153
1.68
1.57
5.1
3.6
25.53
24.96
mmol/l
0.54
25
147
123
1024
1.31
1.57
2.0
1.8
21.03
19.91
nmol/l
0.32
105
836
78
612
1.35
1.50
2.4
1.9
—
—
—
0
0
16
87
1.88
1.48
1.4
1.4
—
—
—
0
0
165
1437
1.27
1.47
2.9
2.7
—
—
—
0
0
9
40
2.28
1.41
1.6
1.4
—
—
—
0
0
21
127
1.69
1.39
2.7
3.3
—
—
—
0
0
5
18
2.80
1.28
1.2
2.3
39.12
41.55
g/l
—
5
18
10
48
2.11
1.28
1.0
1.2
—
—
—
0
0
14
77
1.85
1.27
1.6
1.5
54985.44
15669.48
e6/l
—
9
58
55
420
1.36
1.26
2.2
1.9
—
—
—
0
0
275
2576
1.29
1.23
8.7
7.3
41.44
40.33
mmol/mol
1.15
259
2376
233
2143
1.25
1.20
6.5
4.5
15.59
13.60
mm/h
0.87
219
1970
8
38
2.13
1.19
1.3
1.4
—
—
—
0
0
25
166
1.54
1.18
1.7
2.0
0.52
3.53
ug/l
1.05
20
148
10
50
2.03
1.17
1.6
1.3
—
—
—
0
0
46
346
1.38
1.16
1.4
1.5
—
—
—
0
0
8
39
2.07
1.16
1.4
1.4
—
—
—
0
0
8
39
2.07
1.16
1.4
1.4
—
—
—
0
0
14
80
1.78
1.14
2.3
2.4
121.22
124.66
g/l
—
9
61
5
21
2.40
1.09
1.8
1.7
—
—
—
0
0
5
21
2.40
1.09
1.4
1.1
—
—
—
0
0
5
21
2.40
1.09
1.4
1.1
—
—
—
0
0
33
237
1.43
1.09
4.2
2.8
58.23
60.47
ml/min/173m2
0.11
13
102
279
2636
1.27
1.04
5.8
5.5
4.38
4.40
mmol/l
0.14
255
2418
7
34
2.08
1.03
3.4
3.1
322.00
749.03
mg
—
7
34
267
2512
1.25
1.03
5.0
4.6
1.39
1.26
mmol/l
1.96
240
2270
10
53
1.91
1.02
1.2
1.2
0.76
0.86
g/l
—
10
53
79
658
1.26
0.98
1.9
1.7
1.06
1.55
mg/l
1.58
60
522
5
23
2.19
0.98
1.6
1.2
—
—
—
0
0
5
23
2.19
0.98
1.4
1.2
91.20
94.74
pmol/l
—
5
23
78
649
1.26
0.98
5.7
4.2
204.62
265.07
ng/l
0.16
69
551
9
50
1.82
0.97
1.2
1.2
1.45
1.61
g/l
—
9
50
13
77
1.71
0.96
1.7
1.2
—
—
—
0
0
15
232
0.63
0.96
2.3
1.4
—
—
—
0
0
11
62
1.80
0.95
3.8
3.3
4.43
10.45
pmol/l
3.03
11
62
7
37
1.91
0.94
1.3
1.5
—
—
—
0
0
7
37
1.91
0.94
1.3
1.5
—
—
—
0
0
295
2816
1.27
0.94
17.6
13.1
25.52
24.96
u/l
0.28
287
2716
146
1304
1.20
0.93
5.6
4.3
37.19
96.64
ng/l
0.67
112
1034
21
143
1.50
0.91
2.3
1.8
—
—
—
0
0
14
87
1.63
0.88
1.9
1.6
—
—
—
0
0
10
56
1.81
0.88
1.4
1.6
—
—
—
0
0
282
2685
1.24
0.87
6.6
6.4
2.54
2.54
mmol/l
0.03
257
2446
15
98
1.55
0.79
2.0
3.3
0.00
0.00
g/l
-0.00
15
91
275
2621
1.21
0.79
5.9
5.5
1.37
1.42
mmol/l
1.24
249
2387
50
406
1.27
0.78
5.2
5.4
31.73
32.34
%
0.11
30
259
70
593
1.22
0.76
1.3
1.3
0.50
1.74
u/ml
1.93
16
154
16
108
1.50
0.74
1.9
3.2
0.00
0.00
g/l
-0.00
16
98
7
38
1.86
0.74
1.3
1.4
—
—
—
0
0
153
1395
1.17
0.73
6.9
6.2
2.28
3.04
ug/l
1.00
140
1233
16
109
1.49
0.72
1.1
1.2
—
—
—
0
0
7
40
1.76
0.71
1.0
1.5
—
—
—
0
0
5
26
1.93
0.71
2.2
1.7
—
—
—
0
0
5
28
1.79
0.66
9.8
3.7
64.20
75.20
u/ml
—
5
28
44
361
1.25
0.65
10.1
7.7
—
—
—
0
0
5
29
1.73
0.64
1.4
1.1
—
—
—
0
0
24
183
1.33
0.61
8.5
4.3
43.28
47.35
%
0.35
24
178
51
429
1.22
0.61
1.5
1.3
31.63
13.03
u/ml
0.43
22
151
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
275
2643
1.17
0.60
6.7
5.6
6.33
6.09
mmol/l
1.90
253
2393
223
2113
1.15
0.59
33.6
25.0
330.64
331.58
g/l
0.87
223
2104
15
106
1.43
0.58
2.0
3.2
0.00
0.00
g/l
-0.00
15
92
36
293
1.25
0.58
2.6
2.5
5.25
8.15
ug/l
0.83
28
257
17
124
1.39
0.56
1.1
1.0
—
—
—
0
0
6
38
1.59
0.54
2.0
1.6
—
—
—
0
0
11
74
1.50
0.53
1.5
1.5
—
—
—
0
0
9
64
1.42
0.52
5.4
4.1
16.67
616.17
u/ml
—
9
59
6
40
1.51
0.51
1.2
1.1
—
—
—
0
0
122
1121
1.13
0.50
2.0
2.0
1.40
1.29
mmol/l
0.81
103
905
271
2615
1.15
0.50
29.0
18.8
72.73
75.35
ml/min/173m2
1.31
260
2440
10
67
1.51
0.50
1.1
1.4
—
—
—
0
0
10
67
1.51
0.50
1.5
1.6
—
—
—
0
0
54
467
1.18
0.50
1.3
1.3
25.12
34.57
iu/ml
0.57
20
149
12
84
1.44
0.49
1.6
1.3
—
—
—
0
0
11
153
0.71
0.47
1.3
1.3
—
39.65
—
0
10
5
31
1.62
0.43
1.4
1.4
—
—
—
0
0
8
57
1.41
0.42
2.0
1.4
—
—
—
0
0
44
381
1.18
0.41
4.5
4.6
3.93
41.32
ug/l
1.15
36
326
0
16
0.00
0.41
0.0
1.3
—
159.83
—
0
16
0
16
0.00
0.41
0.0
2.0
—
13.76
—
0
16
0
17
0.00
0.40
0.0
1.7
—
—
—
0
0
0
17
0.00
0.40
0.0
1.7
—
—
—
0
0
0
18
0.00
0.40
0.0
1.7
—
—
—
0
0
5
36
1.39
0.38
2.2
1.7
—
—
—
0
0
9
67
1.35
0.38
1.4
1.5
—
—
—
0
0
12
89
1.36
0.38
1.8
1.6
—
—
—
0
0
13
169
0.76
0.38
2.5
2.6
—
11.29
—
0
9
12
90
1.34
0.36
4.4
3.7
1.00
2.15
index
—
7
54
33
283
1.18
0.35
2.2
2.5
65.62
34.11
u/l
0.51
26
237
21
172
1.23
0.35
1.6
2.0
—
—
—
0
0
12
93
1.30
0.30
1.2
1.6
—
—
—
0
0
8
66
1.22
0.27
1.5
2.1
—
—
—
0
0
8
67
1.20
0.26
1.1
1.4
—
—
—
0
0
8
67
1.20
0.26
1.1
1.4
—
—
—
0
0
9
76
1.19
0.25
2.1
2.2
—
—
—
0
0
6
82
0.73
0.24
1.0
1.8
39.00
45.47
nmol/l
—
6
75
10
78
1.29
0.24
1.2
1.4
—
—
—
0
0
5
39
1.28
0.23
1.4
1.2
0.97
1.62
u/ml
—
5
26
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
10
0.00
0.21
0.0
4.3
—
139.50
—
0
10
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
24
271
0.88
0.21
1.9
1.4
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
156.59
—
0
13
77
815
0.93
0.20
4.4
3.5
0.75
0.82
ug/l
0.28
61
582
6
49
1.23
0.20
1.7
1.5
754.67
970.51
mu/l
—
6
39
6
51
1.18
0.19
1.2
1.5
—
—
—
0
0
8
71
1.13
0.16
1.0
1.2
—
—
—
0
0
8
71
1.13
0.16
1.3
1.1
—
—
—
0
0
8
72
1.11
0.16
1.0
1.2
—
—
—
0
0
10
83
1.21
0.15
1.7
1.6
—
—
—
0
0
6
56
1.07
0.08
2.2
1.8
—
—
—
0
0
5
60
0.83
0.08
1.4
1.7
—
—
—
0
0
8
78
1.03
0.07
1.4
1.4
—
—
—
0
0
14
150
0.93
0.04
3.0
3.2
11.14
2362.41
u/ml
1.29
14
130
111
1117
0.99
0.01
6.0
5.1
20.33
21.83
%
0.69
61
593
10
106
0.94
0.01
1.1
1.3
—
—
—
0
0
68
685
0.99
0.00
3.9
3.2
2.48
2.46
mmol/l
0.79
61
615
16
160
1.00
0.00
1.8
1.8
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
32.28
—
0
5
0
5
0.00
0.00
0.0
1.0
—
1.16
—
0
5
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
7
0.00
-0.00
0.0
2.0
—
94.71
—
0
7
0
8
0.00
-0.00
0.0
1.6
—
7.72
—
0
8
0
8
0.00
-0.00
0.0
1.4
—
10.38
—
0
8
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_BLADDER and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_BLADDER | 1.365 [1.11, 1.68] | 0.004 |
| Birth year | 0.991 [0.98, 1.0] | 0.048 |
During the follow-up period (1.1.1998 — 31.12.2019), 171 out of 564 females with CD2_BENIGN_BLADDER died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_BLADDER | 1.415 [1.17, 1.7] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.011 |
During the follow-up period (1.1.1998 — 31.12.2019), 343 out of 846 males with CD2_BENIGN_BLADDER died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_BLADDER.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.114% | 0.309% |
| 5 | 0.766% | 1.871% |
| 10 | 1.776% | 4.391% |
| 15 | 3.311% | 8.048% |
| 20 | 5.832% | 13.67% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_BLADDER – Benign neoplasm: Bladder
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data